West Pharmaceutical Services, Inc. (WST) Investor Relations Documents

West Pharmaceutical Services, Inc. (WST) investor relations documents from the company's IR site: 17 presentations, 23 press releases; latest deck 2026-04-23. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-23Press releaseWest Reports Second-Quarter 2026 Results
2026-07-21Press releaseWest Declares Quarterly Dividend
2026-07-07Press releaseWest to Host Second-Quarter 2026 Conference Call
2026-07-01Press releaseWest Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System
2026-06-01Press releaseWest Appoints Michel Lagarde to be President and Chief Executive Officer
2026-04-28Press releaseWest to Participate in Upcoming Investor Conferences
2026-04-23Earnings deckQ1 2026 Earnings Presentation
2026-04-23Press releaseWest Reports First-Quarter 2026 Results
2026-04-09Press releaseWest to Host First-Quarter 2026 Conference Call
2026-03-31Press releaseWest Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity
2026-03-09Press releaseEric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services,
2026-02-27Press releaseWest to Participate in Upcoming Investor Conferences
2026-02-17Press releaseWest Announces Quarterly Dividend and Share Repurchase Program
2026-02-12Earnings deckQ4 2025 Earnings Presentation
2026-02-12Press releaseWest Reports Fourth-Quarter and Full-Year 2025 Results
2026-01-29Press releaseWest to Host Fourth-Quarter and Full-Year 2025 Conference Call
2026-01-20Press releaseWest Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
2026-01-12Press releaseWest Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
2025-10-23Press releaseQ3
2025-04-24Press releaseQ1
2025-02-13PresentationPresentation
2025-02-13Press releasePress release
2024-10-24PresentationPresentation
2024-07-25PresentationPresentation
2024-04-25PresentationPresentation
2023-02-16PresentationPresentation
2022-10-27PresentationPresentation
2022-07-28PresentationPresentation
2022-04-28PresentationPresentation
2022-02-17PresentationPresentation
2021-07-29PresentationPresentation
2021-04-29PresentationPresentation
2021-02-18PresentationQ4
2020-10-22PresentationQ3
2020-07-23PresentationQ2
2020-04-23PresentationQ1
Press releaseWest Wins Heart of Pharma Award at 2024 CPHI Pharma Awards
Press releaseWest Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device
Press releaseWest Receives Exhibitor Award at INTERPHEX 2022 for Proprietary DeltaCube™ Modeling Platform
Press releaseWest to Present on Development of Large Volume Delivery Systems, Self-injection Devices and Prefillable Syringe Componen

WST overview · WST earnings · WST financials · WST KPIs · WST ownership · WST peers · WST filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.